Back to Newsroom

Medovex Corporation Comments on President Trump Declaring the Opioid Crisis a National Public Health Emergency

ATLANTA, GA — (Marketwired) — 10/27/17 — Medovex Corp. (NASDAQ: MDVX) (“Medovex” or the “Company”), the developer of the DenerveX® System, a new and novel device designed for enduring relief of Facet Joint Syndrome related to chronic back pain, a non-additive opioid drug alternative capable of restoring a patient to a more normal and active lifestyle, today commented on President Trump declaring the opioid crisis and national public health emergency.